Neisseria meningitidis W-135 in the Basque Country, northern Spain

Clinical Microbiology and Infection

Volumn 12, Issue 8, 2006, Pages 812-815

  Vicente, D ^a   Esnal, O ^a   Marimon, J M ^a   Gastesi, C ^a   Perez Trallero E ^a  

^a HOSPITAL DONOSTIA   (Spain)

Author keywords

Epidemiology; Multilocus sequence typing; Neisseria meningitidis; Pulsed field gel electrophoresis; Serogroup W 135; Typing

Indexed keywords

MENINGOCOCCUS VACCINE;

ADULT; AGED; ARTICLE; BACTERIAL STRAIN; BACTERIUM CARRIER; BACTERIUM ISOLATE; BLOOD SAMPLING; CEREBROSPINAL FLUID ANALYSIS; CHILD; CLONAL VARIATION; DISEASE ASSOCIATION; DNA EXTRACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE SEQUENCE; GENOTYPE; HOUSEKEEPING GENE; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MENINGOCOCCOSIS; MORTALITY; MULTILOCUS SEQUENCE TYPING; NEISSERIA MENINGITIDIS; NEISSERIA MENINGITIDIS W 135; NONHUMAN; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SEQUENCE ANALYSIS; SEROTYPING; SPAIN;

LONCHOCARPUS GLAUCIFOLIUS; NEISSERIA MENINGITIDIS;

EID: 33745599593     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2006.01451.x     Document Type: Article

References (14)

1. Centers for Disease Control and Prevention. Serogroup W-135 meningococcal disease among travelers returning from Saudi Arabia - United States, 2000. MMWR 2000; 49: 345-346.
2. Popovic T, Sacchi CT, Reeves MW et al. Neisseria meningitidis serogroup W135 isolates associated with the ET-37 complex. Emerg Infect Dis, 2000; 6: 428-429.
3. Aguilera JF, Perrocheau A, Meffre C et al. Outbreak of serogroup W135 meningococcal disease after the Hajj pilgrimage, Europe, 2000. Emerg Infect Dis 2002; 8: 761-767.
4. Abdillahi H, Poolman JT. Whole-cell ELISA for typing Neisseria meningitidis with monoclonal antibodies. FEMS Microbiol Lett 1987; 48: 367-371.
5. Vicente D, Esnal O, Michaus L et al. Prevalence of genosubtypes (PorA types) of serogroup B invasive meningococcus in the north of Spain from 2000 to 2003. J Med Microbiol 2005; 54: 381-384.
6. Maiden MC, Bygraves JA, Feil E et al. Multilocus sequence typing: A portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci USA 1998; 95: 3140-3145.
7. Tenover FC, Arbeit RD, Goering RV et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233-2239.
8. Taha MK, Giorgini D, Ducos-Galand M, Alonso JM. Continuing diversification of Neisseria meningitidis W135 as a primary cause of meningococcal disease after emergence of the serogroup in 2000. J Clin Microbiol 2004; 42: 4158-4163.
9. Mayer LW, Reeves MW, Al-Hamdan N et al. Outbreak of W135 meningococcal disease in 2000: Not emergence of a new W135 strain but clonal expansion within the electrophoretic type-37 complex. J Infect Dis 2002; 185: 1596-1605.
10. Molling P, Backman A, Olcen P, Fredlund H. Comparison of serogroup W-135 meningococci isolated in Sweden during a 23-year period and those associated with a recent Hajj pilgrimage. J Clin Microbiol 2001; 39: 2695-2699.
11. Yazdankhah SP, Kriz P, Tzanakaki G et al. Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway. J Clin Microbiol 2004; 42: 5146-5153.
12. Pollard AJ, Ochnio J, Ho M, Callaghan M, Bigham M, Dobsong S. Disease susceptibility to ST11 complex meningococci bearing serogroup C or W135 polysaccharide capsules, North America. Emerg Infect Dis 2004; 10: 1812-1815.
13. Perez-Trallero E, Vicente D, Montes M, Cisterna R. Positive effect of meningococcal C vaccination on serogroup replacement in Neisseria meningitidis. Lancet 2002; 360: 953.
14. MacLennan JM, Urwin R, Obaro S, Griffiths D, Greenwood B, Maiden MC. Carriage of serogroup W135, ET-37 meningococci in The Gambia: implications for immunisation policy? Lancet 2000; 356: 1078.